Enduring Material

Diagnosing and Treating Irritable Bowel Syndrome
View Activity Info
Enter Basic User Info
Create Account
View Content
Take Post Test
Done
View Activity Info
Continue to Enduring Material
 
 
Colorado Medical Society

7351 Lowry Blvd, Suite 110
Denver, CO 80230-6902
General Information
Monday, July 13, 2026 - Tuesday, July 13, 2027
60 minutes
SC Liver Research Consortium
Virtual Conference Room
Diagnosing and Treating Irritable Bowel Syndrome
Colorado Medical Society
Objectives
  • Demonstrate individualized treatment plans for patients by applying new clinical standards and criteria in order to reduce pain and suffering amount in IBS patients.
  • Differentiate the pathways and symptoms of those with Irritable Bowel Syndrome (IBS) in order to identify the disease vectors and potential remedies for IBS-C and IBS-D.
  • Distinguish the benefits and potential side effects of IBS-C therapies in order to align current and emerging therapies with patient criteria for optimal symptom relief and disease management.
  • Translate the lessons from clinical cases presented in order to improve patient outcomes.
Presentations and Speakers
  • Anthony Lembo, MD - Cleveland Clinic Foundation
Available Credits/Points
  • The Colorado Medical Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The Colorado Medical Society designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statements
Speakers:
Anthony Lembo, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • VisceraLabs - Advisory Committee Member - Relationship Has Not Ended
  • Ironwood - Advisory Committee Member - Relationship Has Not Ended
  • Atmo - Advisory Committee Member - Relationship Has Not Ended
  • takeda - Advisory Committee Member - Relationship Has Not Ended
  • Vanda - Contracted Research - Relationship Has Not Ended
  • GSK - Advisory Committee Member - Relationship Has Not Ended
  • Salix - Advisory Committee Member - Relationship Has Not Ended
  • J&J - stock - Relationship Has Not Ended
  • Bristol Myer Squibb - stock - Relationship Has Not Ended

Planners and other Administrative Support:
Paul J. Pockros, MD, Hepatology has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Gilead - Speakers Bureau - Relationship Has Not Ended
  • Gilead - Advisory Committee Member - Relationship Has Not Ended
  • Ipsen - Speakers Bureau - Relationship Has Not Ended
  • Ipsen - Advisory Committee Member - Relationship Has Not Ended
  • Madrigal - Advisory Committee Member - Relationship Has Not Ended
  • Madrigal - Speakers Bureau - Relationship Has Not Ended
  • Novo - Speakers Bureau - Relationship Has Not Ended
  • Mirum - Consulting - Relationship Has Not Ended
  • Intercept - Consulting - Relationship Ended
  • Orphalan - Advisory Committee Member - Relationship Has Not Ended
  • Boston Pharmaceuticals - Review Panel Member - Relationship Ended
  • f5 Therapeutics - Board Member - Relationship Has Not Ended

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and the SC Liver Research Consortium The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
Test Information
100 %
100 %
7/7/2026
Continue to Enduring Material